Stockland has begun construction today on the final piece of MPark Stage 1 - a mixed-use commercial precinct located in Macquarie Park - which includes the new Australian head office for Johnson & Johnson (comprising Johnson & Johnson Medical Pty Ltd and Janssen-Cilag Pty Ltd), a seven-storey workplace building, curated retail and food offering, and a 2,500 square metre open park.
MPark is 12 kilometres north of the City of Sydney. It is well-serviced by public transport and major roads, close to the population catchments of Chatswood and Ryde and walking distance to Lane Cove National Park and near to the Lane Cove River.
Federal Member for Bennelong, Jerome Laxale MP; the Hon. Anoulack Chanthivong MP, NSW Minister for Innovation, Science and Technology; City of Ryde Mayor, Councillor Sarkis Yedelian OAM; City of Ryde CEO, Wayne Rylands; and Johnson & Johnson Managing Directors, Sue Martin and Urs Voegeli, joined Stockland at the milestone sod turn on 13 December 2023.
Stockland's Managing Director and CEO, Tarun Gupta said MPark's Stage 1 is making steady progress since starting construction in July 2021.
"Today marks an exciting milestone as we continue building our $2 billion mixed-use precinct here in the heart of the Macquarie Park Innovation District. We're already seeing strong interest in MPark, having recently welcomed WiSE Medical, and other tenants Demant, CHEP, and established eatery, The Naked Duck, are soon to move into 11 Khartoum Road," Mr Gupta said.
"As we start construction on the final piece of MPark Stage 1, we're looking forward to continuing to create modern and innovative workplaces for our future tenants, like Johnson & Johnson, that focus on driving performance through wellbeing."
Johnson & Johnson's new head office, located at 17 Khartoum Road, will be a six-storey workplace building with three basement levels, designed by international architect, 3XN. It will bring together its medical technology and innovative medicines businesses to create a centre that encourages collaboration, supports multiple ways of working, and ensures the office location is future fit.
Johnson & Johnson Medtech Managing Director, Sue Martin, and Managing Director of Janssen - Johnson & Johnson's innovative medicine business - Urs Voegeli, said the facility would be a new chapter for the organisation at Macquarie Park.
"The existing Johnson & Johnson building has been a well-known landmark since it was completed in the early 1970s. At that time, the surrounding land consisted of market gardens," Ms Martin said.
"We are looking forward to bringing together both the medtech and innovative medicines businesses of Johnson & Johnson, in a future-focused facility that sets us up to provide healthcare solutions for generations to come," Mr Voegeli said.
Upon completion, MPark Stage 1 will comprise three workplace buildings at 11, 15, and 17 Khartoum Road, retail, a data centre, and a 2,500 square metre open park.
The park features a tiered amphitheatre, public art, and is designed to encourage community interaction including powered spaces for food trucks and market stalls. It will become an extension of the workplace, with areas that include outdoor meeting pods with access to Wi-Fi.
The park's design has been informed through collaboration with the Dharug Working Group to embed Designing with Country principles, including food and medicinal plants in the gardens and inscribed storylines and audio elements throughout the park.
MPark will be net zero for base build operations, and the workplace buildings will meet the ESG expectations of future tenants by achieving 6 Star Green Star and 5.5 Star NABERS energy in operation ratings.
Construction of MPark Stage 1 is expected to be complete in 2025.